Analysis of sequence variation among smeDEF multi drug efflux pump genes and flanking DNA from defined 16S rRNA subgroups of clinical Stenotrophomonas maltophilia isolates

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 2, 2004, Pages 348-353

  Gould, Virginia C ^a   Okazaki, Aki ^a   Howe, Robin A ^a   Avison, Matthew B ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Multidrug resistance; Phylogenetic trees; Typing

Indexed keywords

BACTERIAL DNA; BETA LACTAMASE; MEMBRANE PROTEIN; PROTEIN SMED; PROTEIN SMEE; PROTEIN SMEF; PROTEIN SMET; RIBOSOME RNA; RNA 16S; SPACER DNA; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CHROMOSOME; BACTERIUM ISOLATE; DNA FLANKING REGION; GENE LOCATION; GENE LOCUS; GENETIC CODE; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; NONHUMAN; OPERATOR GENE; POLYMERASE CHAIN REACTION; PROMOTER REGION; REPRESSOR GENE; RNA SEQUENCE; SEQUENCE ANALYSIS; STENOTROPHOMONAS MALTOPHILIA; TRANSCRIPTION REGULATION; UNTRANSLATED REGION;

BASE SEQUENCE; BETA-LACTAMASES; BIOLOGICAL TRANSPORT, ACTIVE; DNA PRIMERS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MEMBRANE TRANSPORT PROTEINS; MOLECULAR SEQUENCE DATA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; STENOTROPHOMONAS MALTOPHILIA;

EID: 4444357598     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh367     Document Type: Article

References (23)

1. Denton, M. & Kerr, K. G. (1998). Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clinical Microbiology Reviews 11, 57-80.
2. Avison, M. B., Higgins, C. S., von Heldreich, C. J. et al. (2001). Plasmid location and molecular heterogeneity of the L1 and L2 β-lactamase genes of Stenotrophomonas maltophilia. Antimicrobial Agents and Chemotherapy 45, 413-9.
3. Avison, M. B., Higgins, C. S., Ford, P. J. et al. (2002). Differential regulation of L1 and L2 β-lactamase expression in Stenotrophomonas maltophilia. Journal of Antimicrobial Chemotherapy 49, 387-9.
4. Li, X.-Z., Zhang, L., McKay, G. A. et al. (2003). Role of the acetyltransferase AAC(6′)-lz modifying enzyme in aminoglycoside resistance in Stenotrophomonas maltophilia. Journal of Antimicrobial Chemotherapy 51, 803-11.
5. Li, X.-Z., Zhang, L. & Poole, K. (2002). SmeC, an outer membrane multidrug efflux protein of Stenotrophomonas maltophilia. Antimicrobial Agents and Chemotherapy 46, 333-43.
6. Alonso, A. & Martinez, J. L. (2000). Cloning and characterization of SmeDEF, a novel multidrug efflux pump from Stenotrophomonas maltophilia. Antimicrobial Agents and Chemotherapy 44, 3079-86.
7. Alonso, A. & Martinez, J. L. (2001). Expression of multidrug efflux pump SmeDEF by clinical isolates of Stenotrophomonas maltophilia. Antimicrobial Agents and Chemotherapy 45, 1879-81.
8. Zhang, L., Li, X-Z. & Poole, K. (2001). SmeDEF multidrug efflux pump contributes to intrinsic multidrug resistance in Stenotrophomonas maltophilia. Antimicrobial Agents and Chemotherapy 45, 3497-503.
9. Sanchez, P., Alonso, A. & Martinez, J. L. (2002). Cloning and characterization of SmeT, a repressor of the Stenotrophomonas maltophilia multidrug efflux pump SmeDEF. Antimicrobial Agents and Chemotherapy 46, 3386-93.
10. Sanchez, P., Alonso, A. & Martinez, J. L. (2004). Regulatory regions of smeDEF in Stenotrophomonas maltophilia strains expressing different amounts of the multidrug efflux pump SmeDEF. Antimicrobial Agents and Chemotherapy 48, 2274-6.
11. Berg, G., Roskot, N. & Smalla, K. (1999). Genotypic and phenotypic relationships between clinical and environmental isolates of Stenotrophomonas maltophilia. Journal of Clinical Microbiology 37, 3594-600.
12. Minkwitz, A. & Berg, G. (2001). Comparison of antifungal activities and 16S ribosomal DNA sequences of clinical and environmental isolates of Stenotrophomonas maltophilia. Journal of Clinical Microbiology 39, 139-45.
13. Valdezate, S., Vindel, A., Martin-Davila, P. et al. (2004). High genetic diversity among Stenotrophomonas maltophilia strains despite their originating at a single hospital. Journal of Clinical Microbiology 42, 693-9.
14. Avison, M. B., von Heldreich, C. J., Higgins, C. S. et al. (2000). A TEM-2 β-lactamase encoded on an active Tn 1-like transposon in the genome of a clinical isolate of Stenotrophomonas maltophilia. Journal of Antimicrobial Chemotherapy 46, 879-84.
15. Sorensen, A. B., Duch, M., Jorgensen, P. et al. (1993). Amplification and sequence analysis of DNA flanking integrated proviruses by a simple two-step polymerase chain reaction method. Journal of Virology 67, 7118-24.
16. Avison, M. B., Niumsup, P., Walsh, T. R. et al. (2000). Aeromonas hydrophila AmpH and CepH β-lactamases: derepressed expression in mutants of Escherichia coli lacking creB. Journal of Antimicrobial Chemotherapy 46, 695-702.
17. Coenye, T. & Vandamme, P. (2003). Intragenomic heterogeneity between multiple 16S ribosomal RNA operons in sequenced bacterial genomes. FEMS Microbiology Letters 228, 45-9.
18. Li, X-Z. & Nikaido, H. (2004). Efflux-mediated drug resistance in bacteria. Drugs 64, 159-204.
19. Helfand, M. S. & Bonomo, R. A. (2003). β-Lactamases: a survey of protein diversity. Current Drug Targets. Infectious Disorders 3, 9-23.
20. Wolf, A., Fritze, A., Hagemann, M. et al. (2002). Stenotrophomonas rhizophila sp. nov., a novel plant-associated bacterium with antifungal properties. International Journal of Systematic and Environmental Microbiology 52, 1937-44.
21. Vandamme, P., Pot, B., Gillis, M. et al. (1996). Polyphasic taxonomy, a consensus approach to bacterial systematics. Microbiological Reviews 60, 407-38.
22. Avison, M. B., Underwood, S., Okazaki, A. et al. (2004). Analysis of AmpC β-lactamase expression and sequence in biochemically atypical ceftazidime-resistant Enterobacteriaceae from paediatric patients. Journal of Antimicrobial Chemotherapy 53, 584-91.
23. Higgins, C. S., Avison, M. B., Jamieson, L. et al. (2001). Characterization, cloning and sequence analysis of the inducible Ochrobactrum anthropi AmpC β-lactamase. Journal of Antimicrobial Chemotherapy 47, 745-54.